Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Rejects St. Jude Pacemakers

publication date: Aug 22, 2007
Move Smacks of Retaliation In April, quality control regulators in China found that five heart pacemakers were mislabeled their voltage settings were not correctly identified causing China's government to return the devices to their manufacturer, St. Jude Medical, Inc. (STJ). Although the devices were tested in April, they were returned "recently" and an announcement was made this week. Testing the devices, the Chinese regulators found that their pulse strength varied by more than 2% from stated parameters, the limit for acceptability. More details...


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital